videoDetails![Video Thumbnail](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2020/04/24/00000003_8.jpg?im=Resize=(400))
![Play icon](https://english.cdn.zeenews.com/static/public/icons/icon-vplay.svg)
India’s current production capacity of HCQ is 35-40 cr tablets a month: IDMA
![Video Thumbnail](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2020/04/24/00000003_8.jpg?im=Resize=(400))
Senior vice president of Indian Drug Manufacturers’ Association (IDMA), Viranchi Shah said that India’s current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. While speaking to ANI, he said, “India holds almost 70% global capacity of manufacturing Hydroxychloroquine (HCQ). Our current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India and we have sufficient amount of it to supply outside.”